Entry
Name
Gastric cancer - Mus musculus (house mouse)
Description
Gastric cancer (GC) is one of the world's most common cancers. According to Lauren's histological classification gastric cancer is divided into two distinct histological groups - the intestinal and diffuse types. Several genetic changes have been identified in intestinal-type GC. The intestinal metaplasia is characterized by mutations in p53 gene, reduced expression of retinoic acid receptor beta (RAR-beta) and hTERT expression. Gastric adenomas furthermore display mutations in the APC gene, reduced p27 expression and cyclin E amplification. In addition, amplification and overexpression of c-ErbB2, reduced TGF-beta receptor type I (TGFBRI) expression and complete loss of p27 expression are commonly observed in more advanced GC. The main molecular changes observed in diffuse-type GCs include loss of E-cadherin function by mutations in CDH1 and amplification of MET and FGFR2F.
Class
Human Diseases; Cancer: specific types
BRITE hierarchy
Pathway map
Ortholog table
Organism
Mus musculus (house mouse) [GN:
mmu ]
Gene
67709 Reg4; regenerating islet-derived family, member 4 [KO:K22244 ]
22059 Trp53; transformation related protein 53 [KO:K04451 ]
12575 Cdkn1a; cyclin dependent kinase inhibitor 1A [KO:K06625 ]
13197 Gadd45a; growth arrest and DNA-damage-inducible 45 alpha [KO:K04402 ]
17873 Gadd45b; growth arrest and DNA-damage-inducible 45 beta [KO:K04402 ]
23882 Gadd45g; growth arrest and DNA-damage-inducible 45 gamma [KO:K04402 ]
107986 Ddb2; damage specific DNA binding protein 2 [KO:K10140 ]
22408 Wnt1; wingless-type MMTV integration site family, member 1 [KO:K03209 ]
22413 Wnt2; wingless-type MMTV integration site family, member 2 [KO:K00182 ]
22414 Wnt2b; wingless-type MMTV integration site family, member 2B [KO:K00182 ]
22415 Wnt3; wingless-type MMTV integration site family, member 3 [KO:K00312 ]
22416 Wnt3a; wingless-type MMTV integration site family, member 3A [KO:K00312 ]
22417 Wnt4; wingless-type MMTV integration site family, member 4 [KO:K00408 ]
22418 Wnt5a; wingless-type MMTV integration site family, member 5A [KO:K00444 ]
22419 Wnt5b; wingless-type MMTV integration site family, member 5B [KO:K00444 ]
22420 Wnt6; wingless-type MMTV integration site family, member 6 [KO:K00445 ]
22421 Wnt7a; wingless-type MMTV integration site family, member 7A [KO:K00572 ]
22422 Wnt7b; wingless-type MMTV integration site family, member 7B [KO:K00572 ]
20890 Wnt8a; wingless-type MMTV integration site family, member 8A [KO:K00714 ]
22423 Wnt8b; wingless-type MMTV integration site family, member 8B [KO:K00714 ]
216795 Wnt9a; wingless-type MMTV integration site family, member 9A [KO:K01064 ]
22412 Wnt9b; wingless-type MMTV integration site family, member 9B [KO:K01064 ]
22410 Wnt10b; wingless-type MMTV integration site family, member 10B [KO:K01357 ]
22409 Wnt10a; wingless-type MMTV integration site family, member 10A [KO:K01357 ]
22411 Wnt11; wingless-type MMTV integration site family, member 11 [KO:K01384 ]
93735 Wnt16; wingless-type MMTV integration site family, member 16 [KO:K01558 ]
16973 Lrp5; low density lipoprotein receptor-related protein 5 [KO:K03068 ]
16974 Lrp6; low density lipoprotein receptor-related protein 6 [KO:K03068 ]
13544 Dvl3; dishevelled segment polarity protein 3 [KO:K02353 ]
13542 Dvl1; dishevelled segment polarity protein 1 [KO:K02353 ]
13543 Dvl2; dishevelled segment polarity protein 2 [KO:K02353 ]
14296 Frat1; frequently rearranged in advanced T cell lymphomas [KO:K03069 ]
212398 Frat2; frequently rearranged in advanced T cell lymphomas 2 [KO:K03096 ]
11789 Apc; APC, WNT signaling pathway regulator [KO:K02085 ]
23805 Apc2; APC regulator of WNT signaling pathway 2 [KO:K02085 ]
21414 Tcf7; transcription factor 7, T cell specific [KO:K02620 ]
21415 Tcf7l1; transcription factor 7 like 1 (T cell specific, HMG box) [KO:K04490 ]
21416 Tcf7l2; transcription factor 7 like 2, T cell specific, HMG box [KO:K04491 ]
16842 Lef1; lymphoid enhancer binding factor 1 [KO:K04492 ]
20416 Shc1; src homology 2 domain-containing transforming protein C1 [KO:K06279 ]
216148 Shc2; SHC (Src homology 2 domain containing) transforming protein 2 [KO:K17447 ]
20418 Shc3; src homology 2 domain-containing transforming protein C3 [KO:K17448 ]
271849 Shc4; SHC (Src homology 2 domain containing) family, member 4 [KO:K17449 ]
14784 Grb2; growth factor receptor bound protein 2 [KO:K04364 ]
20662 Sos1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099 ]
20663 Sos2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099 ]
15461 Hras; Harvey rat sarcoma virus oncogene [KO:K02833 ]
16653 Kras; Kirsten rat sarcoma viral oncogene homolog [KO:K07827 ]
18706 Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922 ] [EC:2.7.1.153 ]
18707 Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922 ] [EC:2.7.1.153 ]
74769 Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922 ] [EC:2.7.1.153 ]
18709 Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649 ]
18708 Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649 ]
18710 Pik3r3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649 ]
12576 Cdkn1b; cyclin dependent kinase inhibitor 1B [KO:K06624 ]
19645 Rb1; RB transcriptional corepressor 1 [KO:K06618 ]
21803 Tgfb1; transforming growth factor, beta 1 [KO:K13375 ]
21808 Tgfb2; transforming growth factor, beta 2 [KO:K13376 ]
21809 Tgfb3; transforming growth factor, beta 3 [KO:K13377 ]
12579 Cdkn2b; cyclin dependent kinase inhibitor 2B [KO:K04685 ]
14388 Gab1; growth factor receptor bound protein 2-associated protein 1 [KO:K09593 ]
Compound
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference
Authors
Tan P, Yeoh KG
Title
Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma.
Journal
Reference
Authors
Riquelme I, Saavedra K, Espinoza JA, Weber H, Garcia P, Nervi B, Garrido M, Corvalan AH, Roa JC, Bizama C
Title
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy.
Journal
Reference
Authors
Stock M, Otto F
Title
Gene deregulation in gastric cancer.
Journal
Reference
Authors
Panani AD
Title
Cytogenetic and molecular aspects of gastric cancer: clinical implications.
Journal
Reference
Authors
Vauhkonen M, Vauhkonen H, Sipponen P
Title
Pathology and molecular biology of gastric cancer.
Journal
Reference
Authors
Smith MG, Hold GL, Tahara E, El-Omar EM.
Title
Cellular and molecular aspects of gastric cancer.
Journal
Reference
Authors
Zheng L, Wang L, Ajani J, Xie K.
Title
Molecular basis of gastric cancer development and progression.
Journal
Reference
Authors
Yuasa Y
Title
Control of gut differentiation and intestinal-type gastric carcinogenesis.
Journal
Reference
Authors
Wessler S, Krisch LM, Elmer DP, Aberger F
Title
From inflammation to gastric cancer - the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases.
Journal
Reference
Authors
Yan LH, Wei WY, Xie YB, Xiao Q
Title
New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer.
Journal
Reference
Authors
Hayashi K, Yokozaki H, Goodison S, Oue N, Suzuki T, Lotan R, Yasui W, Tahara E
Title
Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer.
Journal
Reference
Authors
Li X, Wu WK, Xing R, Wong SH, Liu Y, Fang X, Zhang Y, Wang M, Wang J, Li L, Zhou Y, Tang S, Peng S, Qiu K, Chen L, Chen K, Yang H, Zhang W, Chan MT, Lu Y, Sung JJ, Yu J
Title
Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability.
Journal
Reference
Authors
Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA
Title
Gastric cancer-molecular and clinical dimensions.
Journal
Reference
Authors
Bertotti A, Sassi F
Title
Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies.
Journal
Reference
Authors
Appleman LJ
Title
MET signaling pathway: a rational target for cancer therapy.
Journal
Reference
Authors
Eder JP, Vande Woude GF, Boerner SA, LoRusso PM
Title
Novel therapeutic inhibitors of the c-Met signaling pathway in cancer.
Journal
Reference
Authors
Feng Y, Ma PC
Title
Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancer.
Journal
Reference
Authors
Katoh M, Nakagama H
Title
FGF receptors: cancer biology and therapeutics.
Journal
Reference
Authors
Katoh M
Title
FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies.
Journal
Reference
Authors
Katoh M
Title
Genetic alterations of FGF receptors: an emerging field in clinical cancer diagnostics and therapeutics.
Journal
Related pathway
KO pathway
LinkDB
All DBs